Scout | Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)

This grant opportunity is intended to fund basic research exploring how the human microbiome influences anti-tumor immune responses and to find new molecular targets for cancer prevention. Researchers should focus on understanding how interactions between the host and specific microbes or their metabolites affect immune responses related to tumor formation. Applications should thoroughly addre…

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Dates

Opportunity Released: November 3, 2021

Open for Submission: November 3, 2021

Submission Deadline: January 7, 2025

Application Window Closes: January 7, 2025

Keywords

cancer prevention

human microbiome

anti-tumor immune responses

molecular targets

host-microbe interactions

inflammation-associated tumors

sporadic tumor formation

beneficial microbes

immune response modulation

research funding

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers